Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 10, 2017
CymaBay Reports Second Quarter 2017 Financial Results and Provides Corporate Update
NEWARK, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
August 10, 2017
STRATA Skin Sciences Reports Second Quarter 2017 Financial Results
HORSHAM, Pa., Aug. 10, 2017 (GLOBE NEWSWIRE) -- (SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
August 10, 2017
TherapeuticsMD Provides TX-004HR Regulatory Update
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced a regulatory update regarding the New Drug Application (NDA) ...
August 10, 2017
SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties
FOSTER CITY, Calif., Aug. 10, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) (the "Company" or "SciClone") today announced the expiration on August 6, 2017 of ...
August 10, 2017
BioLife Solutions Announces Second Quarter 2017 Financial Results
BOTHELL, Wash., Aug. 10, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation ...
August 10, 2017
Altimmune Announces Second Quarter 2017 Financial Results and Provides Corporate Update
GAITHERSBURG, Md., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three- and six-months months ...
August 10, 2017
Basilea reports improved financial results in half-year 2017 driven by growing product sales; significant progress on partnering and development programs
Basel, Switzerland, August 10, 2017 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today its financial results for the first half of financial year 2017 with product ...
August 10, 2017
Brainstorm to Host Second-Quarter 2017 Earnings Teleconference and Provide Important Corporate Updates, on Wednesday, August 16
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Aug. 10, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
August 10, 2017
Sierra Oncology Reports Second Quarter 2017 Results
VANCOUVER, Aug. 10, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics ...
August 10, 2017
Aradigm Announces Second Quarter 2017 Financial Results
HAYWARD, Calif. -- (BUSINESS WIRE) -- Aradigm Corporation (ARDM) (the “Company”) today announced financial results for the second quarter and six months ended June 30, 2017. ...
August 10, 2017
Zealand Pharma A/S publishes a prospectus regarding listing of 4,375,000 new shares on Nasdaq Copenhagen as part of its issue of American Depositary Shares listed on the Nasdaq in the US
Copenhagen, August 10, 2017 - With reference to company announcements (i) no. 29/2017 dated August 1, 2017 regarding launch of an initial public offering of American ...
August 9, 2017
Vermillion Reports Second Quarter 2017 Results
AUSTIN, Texas, Aug. 9, 2017 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for the second ...
August 9, 2017
BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update
RALEIGH, N.C., Aug. 9, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and six months ended June 30, ...
August 9, 2017
Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
AUSTIN, Texas, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino ...
August 9, 2017
SciClone Reports Second Quarter 2017 Financial Results
FOSTER CITY, Calif., Aug. 9, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) today reported financial results for the quarter ended June 30, 2017. Revenues: In the ...
August 9, 2017
Rockwell Medical Reports Second Quarter Results
WIXOM, Mich., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...
August 9, 2017
Heron Therapeutics Announces Initiation of Phase 3 Program for HTX-011 in Postoperative Pain Following Successful End-of-Phase 2 Meeting with FDA
SAN DIEGO -- (BUSINESS WIRE) -- Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address ...
August 9, 2017
Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress
SAN DIEGO, Calif. -- (BUSINESS WIRE) -- Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to ...
August 9, 2017
AC IMMUNE REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS
Lausanne, Switzerland, August 9, 2017 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
August 9, 2017
Aimmune Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference on Wednesday, August 16th
BRISBANE, Calif. -- (BUSINESS WIRE) -- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that CFO Eric Bjerkholt will ...
Page 98 of 117